Horan Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Horan Securities's BMY Position: Q2 2025 in Review
Horan Securities increased its Bristol-Myers Squibb (BMY) stake by 0.89% in Q2 2025, buying an estimated $3.14K and bringing the position to 7,277 shares worth $337K. The position accounts for 0.12% of the portfolio, ranked #104.
Horan Securities first reported a position in BMY in Q2 2020 and has held it in 20 quarters since. The position peaked at $440K in Q1 2025. 2,297 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- Horan Securities held 7,277 shares of Bristol-Myers Squibb worth $337K as of Q2 2025.
- Horan Securities bought 64 Bristol-Myers Squibb shares in Q2 2025, an estimated $3.14K.
- Bristol-Myers Squibb made up 0.12% of Horan Securities's portfolio in Q2 2025, its #104 holding.
- Horan Securities first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 20 quarters since.
- Horan Securities's Bristol-Myers Squibb position peaked at $440K in Q1 2025.
- 2,297 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on Horan Securities's 13F filing for Q2 2025, filed 6 Aug 2025.